TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma - Wikidata - wikimedia - TriplyDB

TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma

TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma

http://www.wikidata.org/entity/Q34044864

about

HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.TissueCypher(™): A systems biology approach to anatomic pathology.Are biopsy specimens predictive of HER2 status in gastric cancer patients?[Barrett's esophagus. An update].Early HER2 dysregulation in gastric and oesophageal carcinogenesis

P2860

Q26741253-E8D10EAC-D425-46DA-A691-81EF70C316C8 Q26780318-93085FFD-86E8-4BE6-8A46-7F0C6CA545B8 Q34324291-65BEBBD8-5BD6-452F-B905-319F091A5348 Q35140953-28253D78-F9FB-44A7-B272-7873974FF74F Q37522215-F28206E3-FB72-4067-ADAB-4D0C4A5D6B01 Q38925807-36AAF2FC-A800-401F-9831-180D3D28F354 Q40319118-6891CEF5-7F60-49A9-8985-10E75CAA8525 Q44885327-CD333984-85B3-4C5B-9337-0FF284CACBBA Q53095026-8B051DA6-9EC9-4517-87E7-CC9F638E2862 Q58003579-35AD7BD4-57DE-4D19-B563-D1E5D60AC8FB

P2860

TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma

http://www.wikidata.org/entity/Q34044864

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@ast

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@en

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@nl

type

label

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@ast

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@en

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@nl

prefLabel

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@ast

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@en

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@nl

P1433

Q34044864-4154A6EF-D5BA-411D-A025-B6FB761BDDBD

P1476

Q34044864-ABDDBE65-E404-457C-8FE2-71E755349E97

P2093

Q34044864-0864ED1E-9B94-436C-AE0B-0ADEF5976B03

Q34044864-47AC57F1-DF39-4D3F-BEAE-A50E49D0F0E5

Q34044864-6A0CCC1F-2685-48BF-B784-F73D8A4A6448

Q34044864-79676FA1-4C2B-421D-BA82-B7B5D350F75C

Q34044864-7F05E82F-931A-4578-B83B-CCD584CB33E1

Q34044864-9E25F832-6091-4273-98FD-9C882FC61A63

Q34044864-A8E99740-A47F-439F-A0F0-D71143994CA5

Q34044864-C9900995-9131-4D73-851E-4B8C40317E9A

P2860

Q34044864-080FA32B-9648-41DA-B40C-A3B586084A08

Q34044864-177A15C6-34C4-4C80-97DC-382573F50863

Q34044864-1F083811-502C-4685-8D29-538081A65B1E

Q34044864-2D0936F9-6208-438F-8B4E-B20E719BB1B1

Q34044864-2DC107B4-F2DA-4C5F-91EF-BFBEFA5DA04F

Q34044864-46685765-5780-498A-B672-688FAB288D81

Q34044864-5C6A94A7-A1D6-4BC0-B330-3D99BEB4AD6A

Q34044864-5F3313B8-BD61-4D35-ACDD-4A63C887E6B8

Q34044864-66DD9CF2-1DA6-4CE9-B04D-D38A144A427E

Q34044864-6B6CDCFB-1520-4B5E-81BC-77BA786745E3

P304

Q34044864-431C01CA-7449-4B1B-81A8-C01A1F4CCED9

P31

Q34044864-E43A3FDF-A71B-4870-8D74-8CEE41BBC0D2

P356

Q34044864-45B128C5-9939-4AB7-A9C2-185C18B99000

P433

Q34044864-4CE74514-F9ED-4B65-97DC-4BD8E929F8C9

P478

Q34044864-C01B79AF-C359-41BF-8C42-B3E0101B0311

P577

Q34044864-3C0ADDF7-C29A-4867-A188-7EFA6DF05BF4

P5875

Q34044864-5325C85D-6D30-4799-853A-9E6E63D8B477

P698

Q34044864-D2BE0036-68BC-4FC8-A3F7-AE1E9014BB5B

P921

Q34044864-1FBD838F-84E4-42A1-9E8B-0BE32E9D2E5A

Q34044864-F110BC85-51B0-4326-9E6C-EBA6483DA15B

P932

Q34044864-0059B17C-9AFF-48E5-B11A-5D9BE07C10DB

P356

J.1365-2559.2010.03580.X

P1433

P1476

TOPOIIalpha and HER-2/neu over ...... , dysplasia and adenocarcinoma

@en

P2093

Andrea Festa

http://www.w3.org/2001/XMLSchema#string

Elisa Rossi

http://www.w3.org/2001/XMLSchema#string

Francesco Donato

http://www.w3.org/2001/XMLSchema#string

Gabrio Bassotti

http://www.w3.org/2001/XMLSchema#string

Gianpaolo Cengia

http://www.w3.org/2001/XMLSchema#string

Renzo Cestari

http://www.w3.org/2001/XMLSchema#string

Salvatore Grisanti

http://www.w3.org/2001/XMLSchema#string

Vincenzo Villanacci

http://www.w3.org/2001/XMLSchema#string

P2860

Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.

Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.

Recommendations for HER2 testing in the UK.

Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?

Best Practice No 176: Updated recommendations for HER2 testing in the UK

Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.

Focus on Barrett's esophagus and esophageal adenocarcinoma.

HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study.

Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.

P304

81-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2559.2010.03580.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44682155

http://www.w3.org/2001/XMLSchema#string

P698

20557373

http://www.w3.org/2001/XMLSchema#string

P921

P932

2916224

http://www.w3.org/2001/XMLSchema#string